TUBA1A (Tubulin Alpha-1A Chain) is encoded by the TUBA1A gene and constitutes the predominant α-tubulin isoform in the developing human brain. It forms heterodimers with β-tubulin to assemble microtubules, which are vital for:
Neuronal migration and cortical layering during brain development .
Intracellular transport, cell division, and cytoskeletal integrity .
Mutations in TUBA1A disrupt microtubule function, leading to tubulinopathies such as lissencephaly, microcephaly, and intellectual disability .
TUBA1A antibodies are designed to distinguish TUBA1A from other α-tubulin isoforms (e.g., TUBA1B, TUBA1C) due to high sequence homology. Key features include:
Examples of Commercial Antibodies:
ab95966 (Abcam): Rabbit polyclonal antibody validated in WB and IF, detecting a 50 kDa band .
MACO0009 (Assay Genie): Mouse monoclonal antibody for human samples, optimized for WB and IP .
YL1/2 (Thermo Fisher): Binds tyrosylated α-tubulin, serving as a loading control .
Neurite Outgrowth: TUBA1A knockdown in mice impairs neurite extension and growth cone dynamics, linked to MAP1B mislocalization .
Commissure Defects: Tuba1a<sup>N102D</sup> mutants exhibit normal cortical layering but fail to form axon commissures .
Tubulinopathies: Antibodies identify pathogenic mutations (e.g., R402C, L397P) that disrupt tubulin folding or microtubule assembly .
Apoptosis: Codon-modified Tuba1a alleles increase cortical apoptosis, correlating with severe neurodevelopmental phenotypes .
Tagging Methods: Novel TUBA1A-His6 tools enable live visualization of microtubule incorporation without functional impairment .
Post-Translational Modifications: Antibodies detect detyrosination or polyglutamylation, critical for neuronal microtubule specialization .
TUBA1A shares high homology with other α-tubulins but has unique functional domains:
Challenge: TUBA1A shares >90% sequence homology with other α-tubulin isoforms (e.g., TUBA3, TUBA1B) .
Solutions:
Knockdown Validation: Use siRNA targeting TUBA1A in HEK-293T cells to confirm band loss at ~50 kDa .
Post-Translational Modification (PTM) Analysis: Employ antibodies targeting PTM-specific epitopes (e.g., acetyl-K40 in ab95966 ).
Cross-Reactivity Testing: Compare reactivity in lysates from organisms lacking TUBA1A (e.g., Drosophila melanogaster ).
Functional Assays:
Data Interpretation:
Blocking: Use 5% BSA with 0.3% Triton-X 100 to reduce background .
Antigen Retrieval: Optimize heat-mediated retrieval (pH 6.0 citrate buffer) for formalin-fixed brain tissues .
Validation Table:
Transcript vs. Protein Stability: mRNA levels (e.g., TNFRSF12A in scleroderma ) may not correlate with protein due to translational regulation.
Antibody Sensitivity: Compare multiple antibodies (e.g., ab95966 vs. A03989) and confirm with mass spectrometry .
Normalization Errors: Re-express data relative to both GAPDH (mRNA ) and β-actin (protein ).